United States· US:0299-4128_a3c464d3-83b8-495e-bfef-369d23fae338
Cetaphil Eczema Soothing Moisturizer
A medicinal product containing oatmeal, registered in United States by Galderma Laboratories, L.P..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OATMEAL
- Manufacturer
- Galderma Laboratories, L.P.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 13, 2026
Packs & prices · 6
- ndc110299412800296 mL in 1 BOTTLE, PUMP (0299-4128-00)
- ndc11029941280529 mL in 1 BOTTLE (0299-4128-05)
- ndc110299412810473 mL in 1 BOTTLE, PUMP (0299-4128-10)
- ndc110299-4128-00
- ndc110299-4128-05
- ndc110299-4128-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f617d8f1-3681-4ea2-9172-cf9d0bf5c14c GET /v1/drugs/f617d8f1-3681-4ea2-9172-cf9d0bf5c14c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "OATMEAL",
"productndc": "0299-4128",
"dosage_form": "LOTION",
"dea_schedule": null,
"strength_unit": "g/100mL",
"application_number": "M016",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about oatmeal.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.